Point72 Asset Management »

Inhibrx Biosciences shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 26k 94.75

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Amazon (AMZN)
Asml Hldg Nv N Y Registry Shs (ASML)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Procter & Gamble Company (PG)
Arista Networks Com Shs (ANET)
MKS Instruments (MKSI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Snowflake Com Shs (SNOW)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Oracle Corporation (ORCL)
Raytheon Technologies Corp (RTX)
Broadcom (AVGO)

View all positions for Point72 Asset Management

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Morgan Stanley
Sanofi
Viking Global Investors
HighTower Advisors
Bank of America Corporation
BlackRock
Schonfeld Strategic Advisors
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Woodline Partners
Capital Research Global Investors
Partner Fund Management
Sofinnova Ventures

View all funds holding Inhibrx Biosciences